Hôpital Européen Georges Pompidou — Paris

Public research footprint of Hôpital Européen Georges Pompidou, compiled from the ClinicalTrials.gov public registry.

477

Registered studies

175

Active

101

Recruiting now

225

Completed

Stopped or withdrawn

Most-studied conditions

Heart Failure With Reduced Ejection Fraction · Atherosclerotic Cardiovascular Disease (ASCVD) · Metastatic Colorectal Cancer · Non-Small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)
NCT06858761 — Health-economic Assessment of Robot-assisted Bariatric Surgery (Recruiting)
NCT07483827 — A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Européen Georges Pompidou?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.